# A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

> **NCT05219721** · PHASE1 · RECRUITING · sponsor: **Chunrui Li** · enrollment: 18 (estimated)

## Conditions studied

- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia

## Interventions

- **DRUG:** CAR-T (CAR-GPRC5D)

## Key facts

- **NCT ID:** NCT05219721
- **Lead sponsor:** Chunrui Li
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-17
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05219721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05219721, "A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05219721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*